• 
• 
• 
• 
• 
• 

• What is Adult ADD?
• Recognizing Adult ADD
• Adult Screener - (ASRS - V1.1)
• Find a Physician
• Questions to Ask Your Healthcare Professional
• Treatment of Adult ADD
• Living With Adult ADD

Are you living with Adult ADD?

The following questionnaire can be used as a starting point to help you recognize the signs/symptoms of adult ADD but is not meant to replace consultation with a trained healthcare professional. An accurate diagnosis can only be made through a clinical evaluation. Regardless of the questionnaire results, if you have concerns about diagnosis and treatment of ADD, please discuss your concerns with your physician.

Instructions: Please click on the appropriate description for each question below, based on an assessment of yourself and then hit the submit button to see your results. You can clear your answers and start over by clicking on the reset button.

This Adult Self-Report Scale-V1.1 (ASRS-V1.1) Screener is intended for visitors age 18 years or older.

Adult Self-Report Scale (ASRS - V1.1) Screener       from WHO Composite International Diagnostic Interview © World Health Organization.
Questions

The 6-question Adult Self-Report Scale - V 1.1 (ASRS - V 1.1) Screener is a subset of the WHO's 18-question Adult Self-Report Scale - V 1.1 (ASRS - V 1.1) Symptom Checklist. ASRS - V 1.1 Screener COPYRIGHT © 2003 World Health Organization (WHO). Reprinted with permission of WHO. All rights reserved.

FDA Medication Guide | Safety Information and Boxed Warning | Dosing Information | Ask Lilly

Glossary | Site Map | Strattera en Español

AT25696
© 2007 Eli Lilly and Company
This site is intended for U.S. residents only.

Safety Information

In some children and teens, Strattera increases the risk of suicidal thoughts. A combined analysis of 12 studies of Strattera showed that in children and teens this risk was 0.4% for those taking Strattera compared to none for those taking a sugar pill. A similar analysis in adults treated with Strattera did not reveal an increased risk of suicidal thoughts. Call your doctor right away if your child has thoughts of suicide or sudden changes in mood or behavior, especially at the beginning of treatment or after a change in dose.

Strattera should not be taken at the same time or within two weeks of taking an MAOI antidepressant, or if you have narrow angle glaucoma.

Tell your doctor if you or a family member has a history of high or low blood pressure, increased heart rate, heart or blood vessel disease or structural heart defects. If you experience any cardiac symptoms such as chest pain or fainting while taking Strattera you should report them to your doctor right away.

In rare cases, Strattera can cause liver problems. Call your doctor right away if you have itching, dark urine, yellow skin/eyes, upper right-side abdominal tenderness, or unexplained "flu-like" symptoms.

If your child develops new psychological symptoms such as abnormal thoughts/behaviors and/or extreme elevated or irritable moods, while taking Strattera you should report them to your child's doctor right away.

For male patients, if you are taking Strattera and experience priapism, a painful or prolonged erection lasting more than 4 hours, call your doctor right away.

As with all ADHD medications, growth should be monitored during treatment although height and weight data measured for up to 3 years indicates minimal, if any, long-term effects.

In children, the most common side effects were upset stomach, decreased appetite, nausea or vomiting, tiredness, dizziness, and mood swings. In adults, the most common side effects were constipation, dry mouth, nausea, decreased appetite, dizziness, problems sleeping, sexual side effects, problems urinating, and menstrual cramps. Most people in clinical studies who experienced side effects were not bothered enough to stop using Strattera. Strattera has not been tested in children under 6 years of age or in geriatric adults.